Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 114

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 114
---
 have limited specific technical accountants 
 and therefore it is difficult for us to effectively segregate accounting duties and have      
 proper financial reporting, which creates a material weakness in our internal controls over   
 financial reporting.                                                                          |

Accordingly, management concluded there was a material weakness in our internal control over financial reporting at December 31, 2023. Item 9B. Other Information None. Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. None. 49 PART III Item 10. Directors, Executive Officers and Corporate Governance The following are our executive officers and directors and their respective ages and positions as of February 12, 2025.

| Name                     |     | Age |     | Position                            |
| Dave Rosa                |     |  59 |     | Chairman of the Board of Directors. |
| Thyagarajan Ramachandran |     |  49 |     | Chief Financial Officer             |
| Shibu Kizhakevilayil     |     |  53 |     | Head of M&A and Director            |
| Ronald McClurg           |     |  64 |     | Director                            |
| Jainal Bhuiyan           |     |  42 |     | Director                            |

Dave Rosa Mr. Rosa has served as a member of our board of directors since August 2021. Since 2016, Mr. Rosa has been and currently is President and CEO of NeuroOne Medical Technologies (NMTC: Nasdaq), a publicly traded company on the Nasdaq. He also serves on the boards of Biotricity (BTCY: OTC), a publicly traded company on the Over the Counter (OTC) platform, where he currently serves as compensation committee chairman and Neuro Event Labs, a privately held company in Finland, where he currently serves as Chairman of the Board. Mr. Rosa has over 25 years of experience holding a variety of senior management roles representing several medical device markets. His recent experience includes developing early-stage companies to commercialization and Nasdaq listing. Mr. Rosa holds a Master of Business Administration degree from Duquesne University and Bachelor of Science degree in Commerce and Engineering from Drexel University. We believe that Mr. Dave is well qualified to serve as chairman of the Board of Directors. With his entrepreneurial, leadership, operational and capital markets experience. 50 Thyagarajan Ramachandran Mr. Ramachandran has served as our Chief Financial Officer since September 2021. In his current role as CFO at HT